Walgreens Boots Alliance Inc (WBA) Shares Bought by Mariner LLC

Mariner LLC increased its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 92.0% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,317 shares of the pharmacy operator’s stock after acquiring an additional 57,645 shares during the quarter. Mariner LLC’s holdings in Walgreens Boots Alliance were worth $7,877,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Archford Capital Strategies LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at $115,000. Alpha Omega Wealth Management LLC increased its stake in Walgreens Boots Alliance by 100.0% during the 1st quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 800 shares in the last quarter. Financial Advocates Investment Management bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $125,000. Fieldpoint Private Securities LLC increased its stake in Walgreens Boots Alliance by 428.6% during the 4th quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock valued at $134,000 after purchasing an additional 1,500 shares in the last quarter. Finally, Trustcore Financial Services LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $155,000. Institutional investors own 60.30% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Wednesday, May 2nd. The shares were sold at an average price of $65.56, for a total value of $179,372.16. Following the transaction, the director now directly owns 13,679 shares of the company’s stock, valued at approximately $896,795.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 14.80% of the stock is currently owned by insiders.

WBA has been the topic of a number of analyst reports. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a report on Saturday, April 7th. Royal Bank of Canada set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, February 16th. Pivotal Research cut their price objective on shares of Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating on the stock in a report on Friday, March 23rd. BidaskClub downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Thursday, March 22nd. Finally, Leerink Swann cut their price objective on shares of Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating on the stock in a report on Wednesday, May 23rd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $81.90.

Shares of Walgreens Boots Alliance opened at $63.91 on Thursday, Marketbeat reports. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $63.53 billion, a P/E ratio of 12.53, a P/E/G ratio of 1.03 and a beta of 1.14. Walgreens Boots Alliance Inc has a fifty-two week low of $61.56 and a fifty-two week high of $83.89.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.18. The company had revenue of $33.02 billion for the quarter, compared to the consensus estimate of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.36 EPS. analysts expect that Walgreens Boots Alliance Inc will post 5.96 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 12th. Investors of record on Friday, May 18th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date of this dividend was Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 31.37%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply